Table 4_Identification and experimental validation of demethylation-related genes in diabetic nephropathy.xlsx by Hui Miao (143177)

“…This study was to investigate the workings of demethylation in diabetic nephropathy by applying bioinformatics methods.…”

Table 6_Identification and experimental validation of demethylation-related genes in diabetic nephropathy.xlsx by Hui Miao (143177)

“…This study was to investigate the workings of demethylation in diabetic nephropathy by applying bioinformatics methods.…”

Table 10_Identification and experimental validation of demethylation-related genes in diabetic nephropathy.xlsx by Hui Miao (143177)

“…This study was to investigate the workings of demethylation in diabetic nephropathy by applying bioinformatics methods.…”

Table 1_Identification and experimental validation of demethylation-related genes in diabetic nephropathy.xlsx by Hui Miao (143177)

“…This study was to investigate the workings of demethylation in diabetic nephropathy by applying bioinformatics methods.…”

Table 8_Identification and experimental validation of demethylation-related genes in diabetic nephropathy.xlsx by Hui Miao (143177)

“…This study was to investigate the workings of demethylation in diabetic nephropathy by applying bioinformatics methods.…”

Table 9_Identification and experimental validation of demethylation-related genes in diabetic nephropathy.xls by Hui Miao (143177)

“…This study was to investigate the workings of demethylation in diabetic nephropathy by applying bioinformatics methods.…”

Table 2_Identification and experimental validation of demethylation-related genes in diabetic nephropathy.xlsx by Hui Miao (143177)

“…This study was to investigate the workings of demethylation in diabetic nephropathy by applying bioinformatics methods.…”

Data Sheet 1_Clinical management of ectopic Cushing Syndrome in neuroendocrine neoplasms: a national survey.docx by Alice Laffi (22578107)

“…Due to the nonspecific symptoms, EAS is often misdiagnosed, contributing to increased morbidity and complicating clinical management. …”

Table 5_Identification and experimental validation of demethylation-related genes in diabetic nephropathy.xlsx by Hui Miao (143177)

“…This study was to investigate the workings of demethylation in diabetic nephropathy by applying bioinformatics methods.…”

Table 3_Identification and experimental validation of demethylation-related genes in diabetic nephropathy.xlsx by Hui Miao (143177)

“…This study was to investigate the workings of demethylation in diabetic nephropathy by applying bioinformatics methods.…”

Image 1_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…</p>Results<p>E2-treated WT OVX immunized mice after intravaginal HSV-2 challenge showed significantly increased HSV-2-specific IgG2b and IgG2c antibodies in serum and vaginal secretions compared to placebo mice and enhanced B220-CD138+ IgG2c+ plasma cells within the nasal mucosa and vaginal tract 6-weeks after immunization. …”

Data Sheet 1_α-Mangostin prevents diabetic cardiomyopathy by inhibiting oxidative damage and lipotoxicity through the AKT–FOXO1–CD36 pathway.pdf by Xue Bai (129175)

“…</p>Results<p>In HG/F-induced H9C2 cells, A-MG (1 and 3 μM) significantly increased cell viability (p < 0.01) and reduced LDH release (p < 0.05). …”

Figure 3 from Hypoxia-Induced Long Noncoding RNA <i>HIF1A-</i><i>AS2</i> Regulates Stability of MHC Class I Protein in Head and Neck Cancer by Tsai-Tsen Liao (19772247)

“…The infiltrated immune cells that significantly decreased in patients with HIF1A-AS2(H) were labeled in green text and conversely were highlighted in red text. …”

Image 2_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…</p>Results<p>E2-treated WT OVX immunized mice after intravaginal HSV-2 challenge showed significantly increased HSV-2-specific IgG2b and IgG2c antibodies in serum and vaginal secretions compared to placebo mice and enhanced B220-CD138+ IgG2c+ plasma cells within the nasal mucosa and vaginal tract 6-weeks after immunization. …”

Image 5_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…</p>Results<p>E2-treated WT OVX immunized mice after intravaginal HSV-2 challenge showed significantly increased HSV-2-specific IgG2b and IgG2c antibodies in serum and vaginal secretions compared to placebo mice and enhanced B220-CD138+ IgG2c+ plasma cells within the nasal mucosa and vaginal tract 6-weeks after immunization. …”

Postoperative complications and mortality [n(%)]. by Qingwen Cao (22439195)

“…The mortality rates of the HO group at the hospital, 30 days postoperatively, and 90 days postoperatively were 6.3%, 9.6%, and 13.3%, respectively, which were significantly higher than those of the MO (2.7%, 3.6%, 6.2%) and the YO groups (1.2%, 1.8%, 2.4%) (<i><i>P</i></i> < 0.001).…”

P4HA3 deficiency increased sensitization to immune checkpoint inhibitors and P4HA3 could predict the clinical therapeutic effect of PD-1 inhibitor (Camrelizumab). by Hong Yan Huang (20135965)

“…P4HA3 and Ki-67 were decreased in the knockdown groups by siRNA compared to the NC group. …”

Image 3_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…</p>Results<p>E2-treated WT OVX immunized mice after intravaginal HSV-2 challenge showed significantly increased HSV-2-specific IgG2b and IgG2c antibodies in serum and vaginal secretions compared to placebo mice and enhanced B220-CD138+ IgG2c+ plasma cells within the nasal mucosa and vaginal tract 6-weeks after immunization. …”

Information of surgery and anesthesia [n(%)]. by Qingwen Cao (22439195)

“…The mortality rates of the HO group at the hospital, 30 days postoperatively, and 90 days postoperatively were 6.3%, 9.6%, and 13.3%, respectively, which were significantly higher than those of the MO (2.7%, 3.6%, 6.2%) and the YO groups (1.2%, 1.8%, 2.4%) (<i><i>P</i></i> < 0.001).…”

Raw data. by Qingwen Cao (22439195)

“…The mortality rates of the HO group at the hospital, 30 days postoperatively, and 90 days postoperatively were 6.3%, 9.6%, and 13.3%, respectively, which were significantly higher than those of the MO (2.7%, 3.6%, 6.2%) and the YO groups (1.2%, 1.8%, 2.4%) (<i><i>P</i></i> < 0.001).…”